Status:
COMPLETED
Observational Study on Effectiveness and Safety of Integrative Korean Medicine Treatment for Inpatients With Sciatica Due to Lumbar Intervertebral Disc Herniation
Lead Sponsor:
Jaseng Medical Foundation
Conditions:
Sciatica Due to Intervertebral Disc Disorder
Intervertebral Disc Displacement
Eligibility:
All Genders
19-70 years
Brief Summary
Observational study on the effectiveness and safety of integrative Korean medicine treatment for inpatients with sciatica due to lumbar intervertebral disc herniation
Detailed Description
Establishment of a Korean medicine inpatient treatment registry of inpatients with sciatica due to lumbar intervertebral disc herniation with or without spinal stenosis, in conjunction with an observa...
Eligibility Criteria
Inclusion
- Lumbar intervertebral disc herniation as confirmed by a doctor of medicine or a doctor of Korean medicine through an MRI taken within 3 years
- Patients with radiculopathy (ipsilateral or bilateral radiculopathy)
- Patients whose pain intensity of back pain or radiating leg pain is NRS≥5
- Patients aged 19 to 70
- Patients who have agreed to participate in the clinical study and given written informed consent
- Patients admitted to a Korean medicine hospital for treatment
Exclusion
- Patients who have been diagnosed with a serious disease that may cause low back pain or neck pain (e.g. spinal metastasis of tumor, acute fracture, spinal dislocation)
- Patients admitted due to pain caused by traffic accidents
- Patients with progressive neurological deficit or severe neurological symptoms such as spinal cord injury
- Patients with severe mental illness
- Patients with difficulty or refusal to give sign written informed consent
- Patients for whom the researchers judge participation in the clinical study to be difficult
- Diagnosis of lumbar spondylolisthesis of Meyerding Ⅱ or higher by a doctor of medicine or doctor of Korean medicine through X-ray or MRI
Key Trial Info
Start Date :
March 31 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 8 2019
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03750591
Start Date
March 31 2018
End Date
November 8 2019
Last Update
March 13 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi Province, South Korea, 14598
2
Haeundae Jaseng Hospital of Korean Medicine
Busan, South Korea, 48102
3
Daejeon Jaseng Hospital of Korean Medicine
Daejeon, South Korea, 35262
4
Jaseng Hospital of Korean Medicine
Seoul, South Korea, 06110